Hematology/Oncology

Top Story

Anticipated pain leads to higher preprocedure anxiety for needle biopsy patients

Anticipated pain leads to higher preprocedure anxiety for needle biopsy patients
February 14, 2016

Patients who anticipated pain during image-guided needle biopsy of a possible bone or soft tissue tumor experienced higher anxiety preprocedure, according to results.

Researchers prospectively surveyed 65 patients who underwent image-guided needle biopsy of a possible bone or soft tissue tumor to quantify preprocedure and postprocedure levels of anxiety and pain. Researchers also determined demographic and clinical correlates of anxiety, pain and satisfaction with the use of the Spielberger State-Trait Anxiety Inventory and VAS.

Bladder cancer institute at Johns Hopkins named director

February 13, 2016
David J. McConkey, PhD, has been appointed director of the Johns Hopkins Greenberg Bladder Cancer Institute.The institute’s membership includes experts from…

CMS extends 2015 EHR meaningful use attestation deadline

February 12, 2016
CMS has extended the deadline to attest to meaningful use of electronic health records for 2015, according to an email from the agency.Providers in the Medicare &…
In the Journals

Black women with breast cancer less likely to respond to neoadjuvant chemotherapy

February 12, 2016
Black women appeared less likely than those from other racial backgrounds to benefit from neoadjuvant chemotherapy, according to results of a database study.In addition…

Senate Health Committee passes Advancing Research for Neurological Diseases Act of 2015

February 12, 2016
The Senate Health Committee passed the “Advancing Research for Neurological Diseases Act of 2015” (S. 849)” on Tuesday, which will establish a national…
More News Headlines »
CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by educational grants from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty-five percent of lung cancers are non-small…
More »
Video

VIDEO: Microsatellite instability predicts enhanced response to immunotherapy

February 4, 2016
More »
Featured
CME

NSCLC Treatment on Target: Examining New Evidence and Advances

This activity is supported by an educational grant from Genentech, Inc. and Merck & Co., Inc.

Globally, lung cancer is the leading cause of cancer-related deaths. Eighty five percent of lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan
morganatic-roan